• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素和胰高血糖素样肽-1-(7-36)酰胺对大鼠甲状腺C细胞及甲状腺髓样癌CA-77细胞系的影响。

Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.

作者信息

Crespel A, De Boisvilliers F, Gros L, Kervran A

机构信息

INSERM U-376, CHU Arnaud de Villeneuve, Montpellier, France.

出版信息

Endocrinology. 1996 Sep;137(9):3674-80. doi: 10.1210/endo.137.9.8756532.

DOI:10.1210/endo.137.9.8756532
PMID:8756532
Abstract

Glucagon is known to stimulate calcitonin secretion by thyroid C cells over a wide range of concentrations, raising the possibility of its interaction with several types of receptors. This study was designed to characterize receptors that mediate the effect of glucagon on a rat C cell line (CA-77). Binding studies, using radiolabeled [125I]glucagon and [125I]glucagon-like peptide-1-(7-36) amide ([125I]tGLP-1), to CA-77 plasma membranes demonstrated the presence of 1) a glucagon receptor with a dissociation constant (Kd) of 2.3 nM and relative potencies for structurally related peptides as follows: glucagon > oxyntomodulin > > tGLP-1; and 2) a tGLP-1 receptor with a Kd of 0.33 nM and relative potencies as follows: tGLP-1 > oxyntomodulin > glucagon. Glucagon stimulated calcitonin secretion from CA-77 cells in a dose-dependent manner over 4 orders of magnitude, with a maximal response of 312% over the basal value and an ED50 close to 50 nM. tGLP-1 induced a calcitonin release over 2 orders of magnitude, with a maximal response of 170% over the basal value and an ED50 close to 0.2 nM. Glucagon and tGLP-1 stimulated cAMP production in CA-77 cells to similar maximal levels over 4 and 2 orders of magnitude, respectively. The stimulation of cAMP production by glucagon at concentrations over 10 nM was suppressed by the tGLP-1 antagonist exendin-(9-39) amide, whereas the stimulation of calcitonin secretion was only partly abolished. Using a perifusion system of rat thyroid, glucagon and tGLP-1 stimulated calcitonin secretion in a calcium-dependent manner. It is concluded that glucagon and tGLP-1 receptors are expressed in the rat C cell line (CA-77) and in the normal rat thyroid. The effects of glucagon on calcitonin secretion observed at high concentrations are mediated in part through interaction with tGLP-1 receptors and via an additional non-cAMP-mediated mechanism.

摘要

已知胰高血糖素在很宽的浓度范围内可刺激甲状腺C细胞分泌降钙素,这增加了其与几种类型受体相互作用的可能性。本研究旨在鉴定介导胰高血糖素对大鼠C细胞系(CA - 77)作用的受体。使用放射性标记的[125I]胰高血糖素和[125I]胰高血糖素样肽-1-(7 - 36)酰胺([125I]tGLP - 1)对CA - 77细胞膜进行结合研究,结果表明存在:1)一种胰高血糖素受体,其解离常数(Kd)为2.3 nM,对结构相关肽的相对效力如下:胰高血糖素>胃泌酸调节素>>tGLP - 1;以及2)一种tGLP - 1受体,其Kd为0.33 nM,相对效力如下:tGLP - 1>胃泌酸调节素>胰高血糖素。胰高血糖素以剂量依赖方式刺激CA - 77细胞分泌降钙素,作用范围超过4个数量级,最大反应比基础值高312%,半数有效剂量(ED50)接近50 nM。tGLP - 1诱导降钙素释放的作用范围超过2个数量级,最大反应比基础值高170%,ED50接近0.2 nM。胰高血糖素和tGLP - 1分别在4个和2个数量级范围内刺激CA - 77细胞产生cAMP至相似的最大水平。tGLP - 1拮抗剂艾塞那肽-(9 - 39)酰胺可抑制浓度超过10 nM的胰高血糖素对cAMP产生的刺激作用,而对降钙素分泌的刺激作用仅部分被消除。使用大鼠甲状腺灌流系统,胰高血糖素和tGLP - 1以钙依赖方式刺激降钙素分泌。得出的结论是,胰高血糖素和tGLP - 1受体在大鼠C细胞系(CA - 77)和正常大鼠甲状腺中表达。高浓度时观察到的胰高血糖素对降钙素分泌的影响部分是通过与tGLP - 1受体相互作用以及通过一种额外的非cAMP介导机制介导的。

相似文献

1
Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.胰高血糖素和胰高血糖素样肽-1-(7-36)酰胺对大鼠甲状腺C细胞及甲状腺髓样癌CA-77细胞系的影响。
Endocrinology. 1996 Sep;137(9):3674-80. doi: 10.1210/endo.137.9.8756532.
2
Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.胰高血糖素样肽-1-(7-36)酰胺、胃抑制多肽和胰高血糖素在一个分泌生长抑素的细胞系中与一种共同受体相互作用。
Endocrinology. 1993 Aug;133(2):631-8. doi: 10.1210/endo.133.2.8102095.
3
Glucagon acts through its own receptors in the presence of functional glucagon-like peptide-1 receptors on hamster insulinoma.
Endocrinology. 1996 Oct;137(10):4108-14. doi: 10.1210/endo.137.10.8828464.
4
The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system.GLP-1[7-36酰胺]受体的第三个胞质结构域是与腺苷酸环化酶系统偶联所必需的。
Endocrinology. 1996 May;137(5):2175-8. doi: 10.1210/endo.137.5.8612565.
5
tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.胰高糖素样肽-1(tGLP-1)与离体大鼠下丘脑-神经垂体系统中血管加压素和催产素的释放:一种tGLP-1受体激动剂和拮抗剂的作用
J Physiol Pharmacol. 2001 Dec;52(4 Pt 2):781-93.
6
Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.胰高血糖素样肽-1(7-36)酰胺对大鼠下丘脑-神经垂体系统作用的相关机制。
Neuroendocrinology. 2003 Feb;77(2):119-24. doi: 10.1159/000068647.
7
Adenosine A1-receptors inhibit cAMP and Ca2+ mediated calcitonin secretion in C-cells.
Horm Metab Res. 1995 Sep;27(9):408-14. doi: 10.1055/s-2007-979989.
8
Calcitonin secretion and cyclic AMP-efflux from C-cells, stimulated by glucagon and either calcium or Bay K 8644.
Horm Metab Res Suppl. 1989;21:18-21.
9
Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.胃泌酸调节素:通过胰高血糖素样肽-1(7-36)NH2受体对大鼠壁细胞功能产生的一种环磷酸腺苷依赖性刺激。
Digestion. 1996 Nov-Dec;57(6):398-405. doi: 10.1159/000201367.
10
Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1.胰高血糖素样肽-1受体在小鼠C细胞系中的表达:胰高血糖素样肽-1对降钙素基因的调控
FEBS Lett. 1996 Sep 16;393(2-3):248-52. doi: 10.1016/0014-5793(96)00895-2.

引用本文的文献

1
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.肠促胰岛素生理中的葡萄糖依赖性促胰岛素多肽:在健康与疾病中的作用
Endocr Rev. 2025 Jul 15;46(4):479-500. doi: 10.1210/endrev/bnaf006.
2
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.胰高血糖素样肽-1 受体:作用机制与治疗进展。
Signal Transduct Target Ther. 2024 Sep 18;9(1):234. doi: 10.1038/s41392-024-01931-z.
3
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis.
肠道激素对骨代谢的影响及其在骨质疏松症治疗中的可能机制。
Front Pharmacol. 2024 Apr 25;15:1372399. doi: 10.3389/fphar.2024.1372399. eCollection 2024.
4
Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.胰高血糖素样肽-1 类似物激活 AMP 激酶,导致乳腺癌细胞中沃伯格代谢开关的逆转。
Med Oncol. 2024 May 6;41(6):138. doi: 10.1007/s12032-024-02390-w.
5
Links between Thyroid Disorders and Glucose Homeostasis.甲状腺疾病与血糖稳态的关联。
Diabetes Metab J. 2022 Mar;46(2):239-256. doi: 10.4093/dmj.2022.0013. Epub 2022 Mar 24.
6
Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity.发明利拉鲁肽,一种胰高血糖素样肽-1类似物,用于治疗糖尿病和肥胖症。
ACS Pharmacol Transl Sci. 2019 Aug 20;2(6):468-484. doi: 10.1021/acsptsci.9b00048. eCollection 2019 Dec 13.
7
Review article: effects of type 2 diabetes therapies on bone metabolism.综述文章:2型糖尿病治疗对骨代谢的影响
Diabetol Metab Syndr. 2017 Sep 25;9:75. doi: 10.1186/s13098-017-0274-5. eCollection 2017.
8
No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.使用度拉糖肽的患者,若患有既往存在的甲状腺髓样癌,则降钙素无变化。
Diabet Med. 2018 Mar;35(3):381-385. doi: 10.1111/dme.13437.
9
The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.胰高血糖素样肽-1对骨代谢的影响及其可能机制。
Front Endocrinol (Lausanne). 2017 May 3;8:98. doi: 10.3389/fendo.2017.00098. eCollection 2017.
10
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis.骨折风险与胰高血糖素样肽-1受体激动剂的使用无关:一项基于人群的队列分析。
Calcif Tissue Int. 2015 Aug;97(2):104-12. doi: 10.1007/s00223-015-9993-5. Epub 2015 Apr 17.